Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, and SEKISUI Diagnostics, LLC (SEKISUI ), a global manufacturer of innovative ...
EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
The FDA-authorized Metrix COVID/Flu molecular test detects and differentiates COVID, Flu A, and B in 20 minutes. It may be used in home and CLIA-waived settings. SANTA BARBARA, Calif., Feb. 24, 2025 ...
Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.
Scientists and clinicians are learning more about the potential causes of long COVID and how to diagnose it in patients. As we gain insight, there is a greater likelihood that effective treatments for ...
Microbix Biosystms ( ($TSE:MBX) ) has shared an update. Microbix Biosystems Inc. has partnered with SEKISUI Diagnostics to support the U.S.
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...
AI-enabled text-first virtual healthcare clinic Curai Health is partnering with UMass Chan Medical School to study how at-home antigen and molecular tests compare with lab PCR tests in detecting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback